Furthermore, Maltby and coworkers identified DMR at the lymphotoxin α (LTA) locus in CD19+ B cells from RRMS patients, which is thought to be related to the implication of these cells in MS pathogenesis [87]. This evidence concerns the gene CD19 and myeloid sarcoma.